Mirvat Alasnag

Mirvat Alasnag

Director of Catheterization Laboratory

FACC FRCP MD

King Fahd Armed Forces Hospital, Jeddah, SA

  • LinkedIn
  • X
  • OrcidID

Biography

Dr Mirvat Alasnag is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3), joining the board in October 2020 and is also on the editorial board for US Cardiology Review (USC).

Dr Mirvat Alasnag is the Director of the Catheterization Laboratory at the King Fahd Armed Forces Hospital in Jeddah, Saudi Arabia. She was the first female interventional cardiologist in the Gulf region and has since represented women on multiple medical committees, including the Saudi Arabian Cardiac Interventional Society Board & the EAPCI Women’s Steering Committee. She is the current ACCWIC International Working Group Chair and an SCAI WIN member.

Dr Alasnag trained in Clinical Cardiology and Interventional Cardiology at Loma Linda University Medical Center (Loma Linda, California) and Harper University Hospital, Detroit Medical Center (Detroit, Michigan), respectively. Since her graduation in 2009 to date, she has been a practising Interventional Cardiologist at the King Fahd Armed Forces Hospital.

Dr Alasnag is currently serving as a member of the Board of Trustees for SCAI and a member of the ACC Interventional Leadership Council.  Dr Alasnag is the Editor in Chief of Current Cardiovascular Imaging Reports. In addition, she is an Editor/Associate/Contributing Editor for JSCAI, Circulation: Cardiovascular Interventions, PCROnline, Open Heart, Radcliffe Cardiology, ACCEL, Faculty Opinions (ESC) and Cardiovascular Revascularization Medicine.

She is also a member of the ESC Congress Programme Committee, SCCT 2022 Program committee and EuroPCR Board. She is the Interventional Cardiology Section Chief of the Telemedicine Working Group and is active on several other committees at ACC, SCAI, ESC, and SCCT.

Read more

Media

James Spratt, Francis Richard Joshi, Joost Daemen, et al

TCT 23: 5 Trials That Changed My Practice

Mirvat Alasnag,

Watch time: 14m 10s
EP 99: ESC 23 Review: Interventional Trials with Dr Mirvat Alasnag

Mirvat Alasnag, Ankur Kalra,

Listen time: 36m 34s
ESC 23: Day 4 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi,

Watch time: 8m 3s
ESC 23: Day 3 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi,

Watch time: 13m 51s
ESC 23: Day 2 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi,

Watch time: 16m 34s
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi,

Watch time: 13m 28s
Left Main Percutaneous Coronary Revascularization

Mirvat Alasnag, Khalid Al Johani, Abdulramen Al-Moghairi, et al

Watch time: 14m 23s
Left Main Percutaneous Coronary Revascularization

Mirvat Alasnag, Khalid Al Johani, Abdulramen Al-Moghairi, et al

Listen time: 14m 25s
EuroPCR 23: 3 Trials That Will Change Your Practice With Dr Mirvat Alasnag

Mirvat Alasnag,

Watch time: 4m 28s
ACC 23 Interventional Late-breaking Highlights

Mirvat Alasnag, Khaled Al-Shaibi,

Watch time: 16m 22s
AHA 22: 4 Trials That Will Change Your Practice With Interventionalist, Dr Alasnag

Mirvat Alasnag,

Watch time: 12m 38s

Joseph A Hill, Mirvat Alasnag,

Watch time: 5h 4m 36s (26 videos)
ESC 22: 3 Trials That Will Change Your Practice With Dr Alasnag

Mirvat Alasnag,

Watch time: 6m 50s

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)
ACC 22: 5 Trials That Will Change Your Practice with Interventionist, Dr Mirvat Alasnag

Mirvat Alasnag,

Watch time: 6m 15s
EP 55: 5 Interventional trials that will change your practice: Review of ESC 21 with Dr Mirvat Alasnag

Ankur Kalra, Mirvat Alasnag,

Listen time: 53m 38s
USC 2021 Discussion: How Guidelines are Constructed & Elaborated

Michael J Mack, David J Cohen, Mirvat Alasnag, et al

Watch time: 19m 20s
USC 2021 Discussion: Optimal Antiplatelet Regimen in High Bleeding Risk

Mirvat Alasnag, Khaled Al-Shaibi, Roisin Colleran, et al

Watch time: 21m 10s
USC 2021 Discussion: The Impacts of COVID-19 on Clinical Practice and Training

Nosheen Reza, Mirvat Alasnag, Farshad Forouzandeh, et al

Watch time: 24m 45s

Julian Strange, Simon Wilson, James Spratt, et al

TCT Connect 2020 Discussion: The VOYAGER PAD Study

Mirvat Alasnag, Connie N Hess,

Watch time: 17m 13s
TCT Connect 2020 Discussion: The FORECAST Trial

Mirvat Alasnag, Nick Curzen,

Watch time: 18m 1s
Management of ACS during the MERS-CoV Outbreak & Saudi Arabia's Response to COVID-19

Waqar Ahmed, Khaled Al-Shaibi, Mirvat Alasnag, et al

Watch time: 16m 56s

Articles by Mirvat Alasnag, Director of Catheterization Laboratory

Outcomes of Complex Percutaneous Cardiac Interventions in Women

Mirvat Alasnag, Valeria Paradies, Nicola Ryan, et al

Published:

Citation: US Cardiology Review 2023;17:e18.

DOI:

https://doi.org/10.15420/usc.2022.21
An Approach to Non-left Main Bifurcation Lesions: A Contemporary Review

Ali Nazmi Calik, F Aaysha Cader, Erik Rafflenbeul, et al

Published:

Citation: US Cardiology Review 2023;17:e10.

DOI:

https://doi.org/10.15420/usc.2022.25
Left Main Percutaneous Coronary Revascularization

Abdulrahman Almoghairi, Nayef Al-Asiri, Khalid Al Johani, et al

Published:

Citation: US Cardiology Review 2023;17:e09.

DOI:

https://doi.org/10.15420/usc.2022.24
Under-representation of Women as Proceduralists and Patients in TAVR and TMVr Procedures: Data, Implications and Proposed Solutions

Sonya Burgess, F Aaysha Cader, Elizabeth Shaw, et al

Published:

Citation: European Cardiology Review 2022;17:e27.

DOI:

https://doi.org/10.15420/ecr.2022.33
Dual Antiplatelet Regimens for Transcatheter Aortic Valve Replacement and Corresponding Cardiac CT Evaluation of the Leaflets: Single-center Experience

Mirvat Alasnag, Waqar Ahmed, Ibrahim Al-Nasser, et al

Published:

Citation: US Cardiology Review 2022;16:e04.

DOI:

https://doi.org/10.15420/usc.2021.07
Left Main Coronary Artery Interventions

Mirvat Alasnag, Lina Yaqoub, Ammar Saati, et al

Published:

Citation: Interventional Cardiology Review 2019;14(3):124–30.

DOI:

https://doi.org/10.15420/icr.2019.10.R2